Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.

Beharry J, Waters MJ, Drew R, Fink JN, Wilson D, Campbell BCV, Parsons MW, Kleinig TJ, Wu TY.

Stroke. 2020 Mar 25:STROKEAHA119028327. doi: 10.1161/STROKEAHA.119.028327. [Epub ahead of print]

PMID:
32208845
2.

Refusal of Radiation Results in Inferior Survival in Endometrial Cancer.

Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK.

Am J Clin Oncol. 2020 Feb 19. doi: 10.1097/COC.0000000000000681. [Epub ahead of print]

PMID:
32079851
3.

Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial.

Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Zhao H, Alemseged F, Ng F, Bailey P, Rice H, de Villiers L, Dewey HM, Choi PMC, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Kraemer T, Krause M, Cordato D, Field D, Ma H, O'Brien B, Clissold B, Miteff F, Clissold A, Cloud GC, Bolitho LE, Bonavia L, Bhattacharya A, Wright A, Mamun A, O'Rourke F, Worthington J, Wong AA, Levi CR, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Part 2 investigators.

JAMA. 2020 Feb 20. doi: 10.1001/jama.2020.1511. [Epub ahead of print]

PMID:
32078683
4.

Melbourne Mobile Stroke Unit and Reperfusion Therapy: Greater Clinical Impact of Thrombectomy Than Thrombolysis.

Zhao H, Coote S, Easton D, Langenberg F, Stephenson M, Smith K, Bernard S, Cadilhac DA, Kim J, Bladin CF, Churilov L, Crompton DE, Dewey HM, Sanders LM, Wijeratne T, Cloud G, Brooks DM, Asadi H, Thijs V, Chandra RV, Ma H, Desmond PM, Dowling RJ, Mitchell PJ, Yassi N, Yan B, Campbell BCV, Parsons MW, Donnan GA, Davis SM.

Stroke. 2020 Mar;51(3):922-930. doi: 10.1161/STROKEAHA.119.027843. Epub 2020 Feb 12.

PMID:
32078483
5.

Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.

Levi CR, Attia JA, D'Este C, Ryan AE, Henskens F, Kerr E, Parsons MW, Sanson-Fisher RW, Bladin CF, Lindley RI, Middleton S, Paul CL; TIPS (Thrombolysis Implementation in Stroke) Study Group †; TIPS (Thrombolysis Implementation in Stroke) Study Group <xref ref-type="author-note" rid="jah34706-note-1002"><sup>†</sup></xref>.

J Am Heart Assoc. 2020 Feb 4;9(3):e012732. doi: 10.1161/JAHA.119.012732. Epub 2020 Jan 24.

6.

Perfusion Computed Tomography Accurately Quantifies Collateral Flow After Acute Ischemic Stroke.

Lin L, Chen C, Tian H, Bivard A, Spratt N, Levi CR, Parsons MW.

Stroke. 2020 Mar;51(3):1006-1009. doi: 10.1161/STROKEAHA.119.028284. Epub 2020 Jan 17.

PMID:
31948385
7.

Computed Tomography Perfusion Identifies Patients With Stroke With Impaired Cardiac Function.

Garcia-Esperon C, Spratt NJ, Gangadharan S, Miteff F, Bivard A, Lillicrap T, Tomari S, Levi CR, Parsons MW.

Stroke. 2020 Feb;51(2):498-503. doi: 10.1161/STROKEAHA.119.027255. Epub 2020 Jan 3.

PMID:
31896345
8.

Dynamic CT but Not Optimized Multiphase CT Angiography Accurately Identifies CT Perfusion Target Mismatch Ischemic Stroke Patients.

Tian H, Chen C, Garcia-Esperon C, Parsons MW, Lin L, Levi CR, Bivard A.

Front Neurol. 2019 Oct 23;10:1130. doi: 10.3389/fneur.2019.01130. eCollection 2019.

9.

Comparing mismatch strategies for patients being considered for ischemic stroke tenecteplase trials.

Bivard A, Huang X, Levi CR, Campbell BC, Cheripelli BK, Chen C, Kalladka D, Moreton FC, Ford I, Davis SM, Donnan GA, Muir KW, Parsons MW.

Int J Stroke. 2019 Nov 4:1747493019884529. doi: 10.1177/1747493019884529. [Epub ahead of print]

PMID:
31684841
10.

Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.

Campbell BC, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Yan B, Thijs V, Desmond PM, Parsons MW, Donnan GA, Davis SM.

Int J Stroke. 2019 Sep 30:1747493019879652. doi: 10.1177/1747493019879652. [Epub ahead of print]

PMID:
31564231
11.

Modafinil treatment modulates functional connectivity in stroke survivors with severe fatigue.

Visser MM, Goodin P, Parsons MW, Lillicrap T, Spratt NJ, Levi CR, Bivard A.

Sci Rep. 2019 Jul 4;9(1):9660. doi: 10.1038/s41598-019-46149-0.

12.

Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors.

Noll KR, Bradshaw ME, Parsons MW, Dawson EL, Rexer J, Wefel JS.

Curr Treat Options Neurol. 2019 Jun 28;21(7):33. doi: 10.1007/s11940-019-0573-2. Review.

PMID:
31250277
13.

Exploring the relationship between ischemic core volume and clinical outcomes after thrombectomy or thrombolysis.

Chen C, Parsons MW, Levi CR, Spratt NJ, Miteff F, Lin L, Cheng X, Lou M, Kleinig T, Butcher K, Dong Q, Bivard A.

Neurology. 2019 Jul 16;93(3):e283-e292. doi: 10.1212/WNL.0000000000007768. Epub 2019 Jun 17.

PMID:
31209178
14.

Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.

Campbell BCV, Ma H, Ringleb PA, Parsons MW, Churilov L, Bendszus M, Levi CR, Hsu C, Kleinig TJ, Fatar M, Leys D, Molina C, Wijeratne T, Curtze S, Dewey HM, Barber PA, Butcher KS, De Silva DA, Bladin CF, Yassi N, Pfaff JAR, Sharma G, Bivard A, Desmond PM, Schwab S, Schellinger PD, Yan B, Mitchell PJ, Serena J, Toni D, Thijs V, Hacke W, Davis SM, Donnan GA; EXTEND, ECASS-4, and EPITHET Investigators.

Lancet. 2019 Jul 13;394(10193):139-147. doi: 10.1016/S0140-6736(19)31053-0. Epub 2019 May 22.

PMID:
31128925
15.

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?

Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:133-145. doi: 10.1200/EDBK_238353. Epub 2019 May 17. Review.

16.

Response to Late-Window Endovascular Revascularization Is Associated With Collateral Status in Basilar Artery Occlusion.

Alemseged F, Van der Hoeven E, Di Giuliano F, Shah D, Sallustio F, Arba F, Kleinig TJ, Bush S, Dowling RJ, Yan B, Sharma G, Limbucci N, Floris R, Donnan GA, Puetz V, Diomedi M, Parsons MW, Mitchell PJ, Davis SM, Yassi N, Schonewille WJ, Campbell BCV; Basilar Artery Treatment and Management (BATMAN) Collaboration * ; Basilar Artery Treatment and Management (BATMAN) collaborators.

Stroke. 2019 May 16:STROKEAHA118023361. doi: 10.1161/STROKEAHA.118.023361. [Epub ahead of print]

PMID:
31092168
17.

Artificial Neural Network Computer Tomography Perfusion Prediction of Ischemic Core.

Kasasbeh AS, Christensen S, Parsons MW, Campbell B, Albers GW, Lansberg MG.

Stroke. 2019 Jun;50(6):1578-1581. doi: 10.1161/STROKEAHA.118.022649. Epub 2019 May 16.

PMID:
31092162
18.

Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.

Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Christensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA; EXTEND Investigators.

N Engl J Med. 2019 May 9;380(19):1795-1803. doi: 10.1056/NEJMoa1813046.

PMID:
31067369
19.

Influence of occlusion site and baseline ischemic core on outcome in patients with ischemic stroke.

Tian H, Parsons MW, Levi CR, Lin L, Aviv RI, Spratt NJ, Butcher KS, Lou M, Kleinig TJ, Bivard A.

Neurology. 2019 Jun 4;92(23):e2626-e2643. doi: 10.1212/WNL.0000000000007553. Epub 2019 May 1.

PMID:
31043475
20.

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry.

Robinson TG, Bray BD, Paley L, Sprigg N, Wang X, Arima H, Bath PM, Broderick JP, Durham AC, Kim JS, Lavados PM, Lee TH, Martins S, Nguyen TH, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sharma VK, Wang J, Woodward M, Rudd AG, Chalmers J, S Anderson C; ENCHANTED Investigators and the SSNAP Collaboration.

Int J Stroke. 2019 Oct;14(7):678-685. doi: 10.1177/1747493019841246. Epub 2019 Apr 8.

PMID:
30961463
21.

Predicting Modafinil-Treatment Response in Poststroke Fatigue Using Brain Morphometry and Functional Connectivity.

Visser MM, Maréchal B, Goodin P, Lillicrap TP, Garcia-Esperon C, Spratt NJ, Parsons MW, Levi CR, Bivard A.

Stroke. 2019 Mar;50(3):602-609. doi: 10.1161/STROKEAHA.118.023813.

PMID:
30777001
22.

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

Anderson CS, Huang Y, Lindley RI, Chen X, Arima H, Chen G, Li Q, Billot L, Delcourt C, Bath PM, Broderick JP, Demchuk AM, Donnan GA, Durham AC, Lavados PM, Lee TH, Levi C, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Silva F, Song L, Thang NH, Wardlaw JM, Wang JG, Wang X, Woodward M, Chalmers J, Robinson TG; ENCHANTED Investigators and Coordinators.

Lancet. 2019 Mar 2;393(10174):877-888. doi: 10.1016/S0140-6736(19)30038-8. Epub 2019 Feb 7.

PMID:
30739745
23.

Pharmacologic management of cognitive impairment induced by cancer therapy.

Karschnia P, Parsons MW, Dietrich J.

Lancet Oncol. 2019 Feb;20(2):e92-e102. doi: 10.1016/S1470-2045(18)30938-0. Review.

PMID:
30723041
24.

Assessment and management of cognitive changes in patients with cancer.

Parsons MW, Dietrich J.

Cancer. 2019 Jun 15;125(12):1958-1962. doi: 10.1002/cncr.31905. Epub 2019 Jan 22. No abstract available.

PMID:
30668896
25.

Identification of Corticospinal Tract Lesion for Predicting Outcome in Small Perfusion Stroke.

Zhou Y, Zhang R, Yan S, Zhang M, Chen Z, Hu H, Zhang M, Bivard A, Lin L, Parsons MW, Lou M.

Stroke. 2018 Nov;49(11):2683-2691. doi: 10.1161/STROKEAHA.118.021426.

PMID:
30355191
26.

Endovascular Thrombectomy.

Wu Y, Yin C, Yang J, Jiang L, Parsons MW, Lin L.

Stroke. 2018 Nov;49(11):2783-2785. doi: 10.1161/STROKEAHA.118.022919.

PMID:
30355186
27.

Optimal Delay Time of CT Perfusion for Predicting Cerebral Parenchymal Hematoma After Intra-Arterial tPA Treatment.

Wu B, Liu N, Wintermark M, Parsons MW, Chen H, Lin L, Zhou S, Hu G, Zhang Y, Hu J, Li Y, Su Z, Wu X, Zhu G.

Front Neurol. 2018 Aug 21;9:680. doi: 10.3389/fneur.2018.00680. eCollection 2018.

28.

Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.

Coutts SB, Berge E, Campbell BC, Muir KW, Parsons MW.

Int J Stroke. 2018 Dec;13(9):885-892. doi: 10.1177/1747493018790024. Epub 2018 Jul 23. Review.

PMID:
30035698
29.

Validation of computerized episodic memory measures in a diverse clinical sample referred for neuropsychological assessment.

Busch RM, Hogue O, Ferguson L, Parsons MW, Kubu CS, Floden DP.

Clin Neuropsychol. 2019 Apr;33(3):557-570. doi: 10.1080/13854046.2018.1488995. Epub 2018 Jul 11.

30.

Intravenous Thrombolysis May Not Improve Clinical Outcome of Acute Ischemic Stroke Patients Without a Baseline Vessel Occlusion.

Tian H, Parsons MW, Levi CR, Cheng X, Aviv RI, Spratt NJ, Kleinig TJ, O'Brien B, Butcher KS, Lin L, Zhang J, Dong Q, Chen C, Bivard A.

Front Neurol. 2018 Jun 6;9:405. doi: 10.3389/fneur.2018.00405. eCollection 2018.

31.

Short- and Long-Term Efficacy of Modafinil at Improving Quality of Life in Stroke Survivors: A Post Hoc Sub Study of the Modafinil in Debilitating Fatigue After Stroke Trial.

Lillicrap TP, Levi CR, Holliday E, Parsons MW, Bivard A.

Front Neurol. 2018 Apr 25;9:269. doi: 10.3389/fneur.2018.00269. eCollection 2018.

32.

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.

Campbell BCV, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Dowling RJ, Yan B, Bush SJ, Dewey HM, Thijs V, Scroop R, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Ang T, Miteff F, Levi CR, Rodrigues E, Zhao H, Salvaris P, Garcia-Esperon C, Bailey P, Rice H, de Villiers L, Brown H, Redmond K, Leggett D, Fink JN, Collecutt W, Wong AA, Muller C, Coulthard A, Mitchell K, Clouston J, Mahady K, Field D, Ma H, Phan TG, Chong W, Chandra RV, Slater LA, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Bladin CF, Sharma G, Desmond PM, Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Investigators.

N Engl J Med. 2018 Apr 26;378(17):1573-1582. doi: 10.1056/NEJMoa1716405.

33.

Imaging selection for acute stroke intervention.

Campbell BC, Parsons MW.

Int J Stroke. 2018 Aug;13(6):554-567. doi: 10.1177/1747493018765235. Epub 2018 Mar 15. Review.

PMID:
29543140
34.

Correction for Delay and Dispersion Results in More Accurate Cerebral Blood Flow Ischemic Core Measurement in Acute Stroke.

Lin L, Bivard A, Kleinig T, Spratt NJ, Levi CR, Yang Q, Parsons MW.

Stroke. 2018 Apr;49(4):924-930. doi: 10.1161/STROKEAHA.117.019562. Epub 2018 Mar 2.

PMID:
29500248
35.

Tissue Is More Important than Time in Stroke Patients Being Assessed for Thrombolysis.

Bivard A, Spratt N, Miteff F, Levi C, Parsons MW.

Front Neurol. 2018 Feb 5;9:41. doi: 10.3389/fneur.2018.00041. eCollection 2018.

36.

Endovascular Thrombectomy for Ischemic Stroke Increases Disability-Free Survival, Quality of Life, and Life Expectancy and Reduces Cost.

Campbell BCV, Mitchell PJ, Churilov L, Keshtkaran M, Hong KS, Kleinig TJ, Dewey HM, Yassi N, Yan B, Dowling RJ, Parsons MW, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Rice H, de Villiers L, Ma H, Desmond PM, Meretoja A, Cadilhac DA, Donnan GA, Davis SM; EXTEND-IA Investigators.

Front Neurol. 2017 Dec 14;8:657. doi: 10.3389/fneur.2017.00657. eCollection 2017.

37.

Neurocognitive aspects of brain metastasis.

Wefel JS, Parsons MW, Gondi V, Brown PD.

Handb Clin Neurol. 2018;149:155-165. doi: 10.1016/B978-0-12-811161-1.00012-8. Review.

PMID:
29307352
38.

Thresholds for infarction vary between gray matter and white matter in acute ischemic stroke: A CT perfusion study.

Chen C, Bivard A, Lin L, Levi CR, Spratt NJ, Parsons MW.

J Cereb Blood Flow Metab. 2019 Mar;39(3):536-546. doi: 10.1177/0271678X17744453. Epub 2017 Nov 27.

39.

Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion.

Alemseged F, Shah DG, Bivard A, Kleinig TJ, Yassi N, Diomedi M, Di Giuliano F, Sharma G, Drew R, Yan B, Dowling RJ, Bush S, Sallustio F, Caltagirone C, Mercuri NB, Floris R, Parsons MW, Levi CR, Mitchell PJ, Davis SM, Campbell BC.

Int J Stroke. 2019 Jul;14(5):540-547. doi: 10.1177/1747493017744465. Epub 2017 Nov 21.

PMID:
29160168
40.

The influence of initial stroke severity on mortality, overall functional outcome and in-hospital placement at 90 days following acute ischemic stroke: A tertiary hospital stroke register study.

Bhaskar S, Stanwell P, Bivard A, Spratt N, Walker R, Kitsos GH, Parsons MW, Evans M, Jordan L, Nilsson M, Attia J, Levi C.

Neurol India. 2017 Nov-Dec;65(6):1252-1259. doi: 10.4103/0028-3886.217947.

PMID:
29133696
41.

Visibility of CT Early Ischemic Change Is Significantly Associated with Time from Stroke Onset to Baseline Scan beyond the First 3 Hours of Stroke Onset.

Gao J, Parsons MW, Kawano H, Levi CR, Evans TJ, Lin L, Bivard A.

J Stroke. 2017 Sep;19(3):340-346. doi: 10.5853/jos.2016.01424. Epub 2017 Sep 29.

42.

Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.

Wang X, Robinson TG, Lee TH, Li Q, Arima H, Bath PM, Billot L, Broderick J, Demchuk AM, Donnan G, Kim JS, Lavados P, Lindley RI, Martins SO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sharma VK, Thang NH, Wang JG, Woodward M, Anderson CS, Chalmers J; Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) Investigators.

JAMA Neurol. 2017 Nov 1;74(11):1328-1335. doi: 10.1001/jamaneurol.2017.2286. Erratum in: JAMA Neurol. 2018 Mar 1;75(3):384.

43.

Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study.

Campbell BC, Mitchell PJ, Churilov L, Yassi N, Kleinig TJ, Yan B, Dowling RJ, Bush SJ, Dewey HM, Thijs V, Simpson M, Brooks M, Asadi H, Wu TY, Shah DG, Wijeratne T, Ang T, Miteff F, Levi C, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Bailey P, Rice H, de Villiers L, Scroop R, Collecutt W, Wong AA, Coulthard A, Barber PA, McGuinness B, Field D, Ma H, Chong W, Chandra RV, Bladin CF, Brown H, Redmond K, Leggett D, Cloud G, Madan A, Mahant N, O'Brien B, Worthington J, Parker G, Desmond PM, Parsons MW, Donnan GA, Davis SM; EXTEND-IA TNK Investigators.

Int J Stroke. 2018 Apr;13(3):328-334. doi: 10.1177/1747493017733935. Epub 2017 Sep 27.

PMID:
28952914
44.

Influence of Penumbral Reperfusion on Clinical Outcome Depends on Baseline Ischemic Core Volume.

Chen C, Parsons MW, Clapham M, Oldmeadow C, Levi CR, Lin L, Cheng X, Lou M, Kleinig TJ, Butcher KS, Dong Q, Bivard A.

Stroke. 2017 Oct;48(10):2739-2745. doi: 10.1161/STROKEAHA.117.018587. Epub 2017 Sep 8.

PMID:
28887396
45.

Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).

Robinson TG, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Demchuk AM, Donnan GA, Kim JS, Lavados PM, Lee TH, Lindley RI, Martins SCO, Olavarria VV, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Nguyen TH, Wang JG, Woodward M, Chalmers J, Anderson CS; ENCHANTED Investigators.

Stroke. 2017 Jul;48(7):1877-1883. doi: 10.1161/STROKEAHA.116.016274. Epub 2017 Jun 15.

PMID:
28619989
46.

Tenecteplase in ischemic stroke offers improved recanalization: Analysis of 2 trials.

Bivard A, Huang X, Levi CR, Spratt N, Campbell BCV, Cheripelli BK, Kalladka D, Moreton FC, Ford I, Bladin CF, Davis SM, Donnan GA, Muir KW, Parsons MW.

Neurology. 2017 Jul 4;89(1):62-67. doi: 10.1212/WNL.0000000000004062. Epub 2017 Jun 2.

PMID:
28576782
47.

The Basilar Artery on Computed Tomography Angiography Prognostic Score for Basilar Artery Occlusion.

Alemseged F, Shah DG, Diomedi M, Sallustio F, Bivard A, Sharma G, Mitchell PJ, Dowling RJ, Bush S, Yan B, Caltagirone C, Floris R, Parsons MW, Levi CR, Davis SM, Campbell BC.

Stroke. 2017 Mar;48(3):631-637. doi: 10.1161/STROKEAHA.116.015492. Epub 2017 Feb 22.

PMID:
28228577
48.

Determining the benefits of transcranial direct current stimulation on functional upper limb movement in chronic stroke.

Marquez JL, Conley AC, Karayanidis F, Miller J, Lagopoulos J, Parsons MW.

Int J Rehabil Res. 2017 Jun;40(2):138-145. doi: 10.1097/MRR.0000000000000220.

PMID:
28196011
49.

Prediction of final infarct volume on subacute MRI by quantifying cerebral edema in ischemic stroke.

Tipirneni-Sajja A, Christensen S, Straka M, Inoue M, Lansberg MG, Mlynash M, Bammer R, Parsons MW, Donnan GA, Davis SM, Albers GW.

J Cereb Blood Flow Metab. 2017 Aug;37(8):3077-3084. doi: 10.1177/0271678X16683960. Epub 2016 Jan 1.

50.

Perfusion computed tomography in patients with stroke thrombolysis.

Kawano H, Bivard A, Lin L, Ma H, Cheng X, Aviv R, O'Brien B, Butcher K, Lou M, Zhang J, Jannes J, Dong Q, Levi CR, Parsons MW.

Brain. 2017 Mar 1;140(3):684-691. doi: 10.1093/brain/aww338.

Supplemental Content

Loading ...
Support Center